Elewski, B., Menter, A., Crowley, J., Tyring, S., Zhao, Y., Lowry, S., Rozzo, S., Mendelsohn, A., Parno, J., & Gordon, K. (2018). Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 2(S1), S22. https://doi.org/10.25251/skin.2.supp.22